Healthcare Services Group, Inc. (HCSG)

NASDAQ: HCSG · Real-Time Price · USD

25.30

+0.51 (2.06%)

At close: Oct 23, 2026, 4:00 PM EDT

25.21

-0.09 (-0.36%)

After-hours: Oct 23, 2026, 7:30 PM EDT

Healthcare Services Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,736	1,347	851	766	889	1,326
Market Cap Growth	27.21%	58.25%	11.16%	-13.86%	-32.95%	-36.59%
Enterprise Value	1,579	1,184	790	708	815	1,139
Last Close Price	25.30	19.12	11.62	10.37	12.00	16.82

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	17.01	22.81	21.57	19.95	25.96	27.32
Forward PE	21.85	20.89	14.23	15.25	20.62	23.87
PS Ratio	0.92	0.73	0.50	0.46	0.53	0.81
PB Ratio	3.24	2.64	1.70	1.68	2.13	2.93
P/TBV Ratio	4.09	3.18	2.05	2.08	2.72	3.71
P/FCF Ratio	11.69	9.68	34.79	20.10	-	42.20
P/OCF Ratio	11.25	9.29	27.64	17.61	-	35.74
PEG Ratio	-	1.44	1.44	1.70	2.29	1.99

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	0.84	0.64	0.46	0.42	0.48	0.69
EV/EBITDA Ratio	12.93	20.76	15.24	12.67	13.10	17.33
EV/EBIT Ratio	13.87	24.38	17.53	14.77	15.38	19.83
EV/FCF Ratio	10.63	8.51	32.27	18.60	-	36.25

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.02	0.03	0.03	0.10	0.09	0.04
Debt / EBITDA Ratio	0.09	0.22	0.26	0.67	0.55	0.24
Debt / FCF Ratio	-	0.11	0.67	1.15	-	0.57
Net Debt / Equity Ratio	-0.30	-0.30	-0.18	-0.23	-0.20	-0.37
Net Debt / EBITDA Ratio	-1.29	-2.68	-1.75	-1.86	-1.34	-2.55
Net Debt / FCF Ratio	-	-1.10	-3.71	-2.73	6.21	-5.33
Asset Turnover	2.27	2.30	2.15	2.21	2.26	2.10
Inventory Turnover	-	95.26	84.46	73.49	63.46	49.01
Quick Ratio	2.44	2.95	2.54	2.45	2.46	2.55
Current Ratio	2.82	3.38	2.89	2.64	2.69	2.86
Return on Equity (ROE)	20.41%	11.69%	8.25%	8.77%	7.86%	10.40%
Return on Assets (ROA)	8.60%	3.80%	3.53%	3.97%	4.42%	4.60%
Return on Invested Capital (ROIC)	25.05%	11.02%	8.81%	10.09%	13.12%	16.44%
Return on Capital Employed (ROCE)	17.70%	7.80%	7.40%	8.40%	10.00%	9.80%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	5.88%	4.38%	4.64%	5.01%	3.85%	3.66%
FCF Yield	8.55%	10.33%	2.87%	4.97%	-1.50%	2.37%
Dividend Yield	-	-	-	-	5.34%	4.66%
Payout Ratio	-	-	-	-	185.07%	128.19%
Buyback Yield / Dilution	4.25%	1.29%	0.47%	0.01%	0.81%	-0.24%
Total Shareholder Return	4.25%	1.29%	0.47%	0.01%	6.16%	4.42%

SEC Filings: 10-K · 10-Q